From August 1, 2023 to December 31, 2023, the company has repurchased 3,391,244 shares, representing 4.09% for $4.85 million. With this, the company has completed the repurchase of 3,391,244 shares, representing 4.09% for $4.85 million under the buyback announced on August 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +6.67% | -4.19% | -15.79% |
06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.79% | 129M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- Tranche Update on I-Mab's Equity Buyback Plan announced on August 17, 2023.